Caris Biorepository Research Protocol
Hematopoietic Malignancies
Solid Tumor
18 Years and older, Male and Female
Summary
The Biorepository for Caris Life Sciences is designed for the purpose of making quality
biospecimens and associated clinical data available for research studies related to
advancing precision medicine and improving care for patients.
The Caris Biorepository is a repository of prospectively collected biological specimens
and associated clinical and demographic data gathered from multiple sources to be stored,
used and shared for research. Caris Life Sciences will maintain the data and specimens
and will control access to and use of the information and specimens by multiple
individuals for multiple purposes which may evolve over time.
Objectives
The Caris Biorepository is an effort toward defining the future of medicine incorporating
the discoveries of the genomic era by providing physicians, researchers and scientists
access to quality human specimens and data aimed at improving human health and fighting
disease. This will be accomplished through acquiring and sharing valuable biospecimen
information and clinical outcomes in a collaborative, secure environment. The Caris
Biorepository will bridge the gap and correlate human specimens with clinical and
specimen data valuable to multiple and varying entities interested in advancing science
with precision medicine by targeting disease treatments.
The objective of this project is to develop and implement a state-of-the-science
Biorepository that ensures molecular integrity and clinical relevance of human
biospecimens used in research and clinical medicine. The Caris Biorepository will also
provide vital biospecimens and data to internal researchers and external research
collaborators such as government, academia and industry collaborators for the use of drug
development discoveries, clinically relevant research trials, publications and posters,
and the implementation of future healthcare policies. This project may also impact
characterization of trends in practice patterns and their relation to patient outcomes as
well as the economic implications of differing evaluation, treatment and management
paradigms.
Eligibility
- 18 years of age or older
- Capacity to provide informed consent
Treatment Sites in Georgia
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts...
Click here to learn more about clinical trials.